1.46BMarket Cap-20469P/E (TTM)
10.090High9.690Low1.71MVolume9.750Open9.750Pre Close17.00MTurnover1.25%Turnover RatioLossP/E (Static)146.00MShares12.12052wk High10.95P/B1.37BFloat Cap7.05052wk Low--Dividend TTM136.45MShs Float37.780Historical High--Div YieldTTM4.10%Amplitude5.450Historical Low9.938Avg Price1Lot Size
Zuora Stock Forum
No one covering Zuora?
Today’s companies are looking for a new level of business agility to deploy new business models, launch product lines, and expand internationally. At the same time, they need their applications and platforms to help them scale to IPO and beyond. These new integrated solutions will deliver finance teams more agility, power enhanced subscription analytics, and make it easier than ever to deploy and adopt technology from two enterprise leaders.
$VIZIO(VZIO.US)$
$Fulgent Genetics(FLGT.US)$
$Cara Therapeutics(CARA.US)$
$KnowBe4, Inc.(KNBE.US)$
$Coursera(COUR.US)$
$Intellia Therapeutics(NTLA.US)$
$Natera(NTRA.US)$
$DraftKings(DKNG.US)$
$Natural Alternatives International(NAII.US)$
$Revolve Group(RVLV.US)$
$A10 Networks(ATEN.US)$
$Zuora(ZUO.US)$
Insider Buying
$Spero Therapeutics(SPRO.US)$
$Lumos Pharma(LUMO.US)$
$Oscar Health(OSCR.US)$
$Phibro Animal Health(PAHC.US)$
No comment yet